← SynDRA
PAZUFLOXACIN
SynDRA canonical compound SYN0007698 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
| Indication | bacterial septicemia | peritonitis | pneumonia |
|---|
| Disease area | infectious disease |
|---|
All known targets
- Bact gyrA; Bact gyrB
- Bact parC
- TOP2A
- TOP2B
Mechanisms of action (all sources)
- TOP2A INHIBITOR
- DNA topoisomerase II inhibitor
- TOP2B INHIBITOR
- topoisomerase inhibitor
- Inhibitor
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antineoplastic Agents
- Antitubercular Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- pazufloxacin mesilate
- pazufloxacin mesylate
- Pazufloxacine
- Pazufloxacino
- T-3761
- T 3761
- UNII-4CZ1R38NDI
- 4CZ1R38NDI
- NCGC00167534-01
- DSSTox_CID_26697
- DSSTox_RID_81831
- DSSTox_GSID_46697
- Pazufloxacin [INN]
- SMR000466380
- CCRIS 7312
- CAS-127045-41-4
- PZFX
- Pazufloxacin (JAN/INN)
- SCHEMBL34460
- 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)-
- MLS000759513
- MLS001424116
- CHEMBL240163
- DTXSID5046697
- CHEBI:94700
- HY-B0724B
- HMS2051B05
- HMS2090H07
- BCP12954
- LSM-5745
- RKL10069
- ZINC3779726
- Tox21_112531
- BDBM50248017
- MFCD00865012
- AKOS015900451
- Tox21_112531_1
- AC-3506
Look up PAZUFLOXACIN in the interactive SynDRA portal →